Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.140
+0.020 (1.79%)
Mar 11, 2026, 4:00 PM EDT - Market closed
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $100.63 million as of March 11, 2026. Its market cap has increased by 331.97% in one year.
Market Cap
100.63M
Enterprise Value
61.68M
1-Year Change
331.97%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $100.63M, a decrease of -60.76%. That is a compound annual growth rate of -19.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 98.87M | -17.04% |
| Dec 31, 2025 | 119.17M | 308.99% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dogwood Therapeutics | 96.22M |
| Anixa Biosciences | 95.13M |
| Vivani Medical | 93.43M |
| TuHURA Biosciences | 91.08M |
| MAIA Biotechnology | 90.34M |
| iBio, Inc. | 90.16M |
| Kazia Therapeutics | 89.89M |
| PMV Pharmaceuticals | 87.27M |